Robert M. Chanock

Robert M. Chanock's AcademicInfluence.com Rankings

Robert M. Chanock

Medical

#194

World Rank

#289

Historical Rank

#90

USA Rank

Pediatrics

World Rank

#11

Historical Rank

USA Rank

medical Degrees

Robert M. Chanock

Biology

#1404

World Rank

#2363

Historical Rank

#707

USA Rank

Virology

#28

World Rank

#30

Historical Rank

#11

USA Rank

biology Degrees

Download Badge

Medical
Biology

Why Is Robert M. Chanock Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Merritt Chanock was an American pediatrician and virologist who made major contributions to the prevention and treatment of childhood respiratory infections in more than 50 years spent at the National Institute of Allergy and Infectious Diseases.

(See a Problem?)

Robert M. Chanock's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. (1969) (1760)
Visualization by Immune Electron Microscopy of a 27-nm Particle Associated with Acute Infectious Nonbacterial Gastroenteritis (1972) (1054)
An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. (1969) (965)
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. (1991) (692)
Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. (1962) (686)
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. (1973) (564)
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. (1967) (511)
Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. (1973) (446)
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. (1976) (444)
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. (1995) (443)
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. (1985) (381)
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. (1991) (362)
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. (1974) (337)
Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys (1996) (326)
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production (1966) (318)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. (2000) (315)
Association of serum anti-neuraminidase antibody with resistance to influenza in man. (1972) (310)
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. (1986) (308)
Role of early region 3 (E3) in pathogenesis of adenovirus disease. (1989) (293)
The pathogenesis of respiratory syncytial virus infection in cotton rats. (1978) (291)
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine (1986) (287)
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. (2001) (275)
Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. (1969) (271)
Protective effect of antibody to parainfluenza type 1 virus. (1966) (269)
Biological Properties of Norwalk Agent of Acute Infectious Nonbacterial Gastroenteritis (1972) (268)
Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. (1981) (259)
Human rotavirus type 2: cultivation in vitro. (1980) (256)
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. (1967) (246)
Pediatric viral gastroenteritis during eight years of study (1983) (237)
Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats (1985) (232)
Newly recognized myxoviruses from children with respiratory disease. (1958) (227)
Reassortant rotaviruses as potential live rotavirus vaccine candidates (1985) (226)
ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION. (1965) (225)
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. (1990) (224)
An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. (1966) (222)
Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. (1978) (214)
Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. (1985) (214)
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. (1971) (214)
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus (1986) (208)
Adsorption of Mycoplasma pneumoniae to Neuraminic Acid Receptors of Various Cells and Possible Role in Virulence (1968) (207)
Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. (1996) (200)
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. (1971) (199)
Color Test for the Measurement of Antibody to T-Strain Mycoplasmas (1966) (194)
SEROEPIDEMIOLOGIC STUDIES OF CORONAVIRUS INFECTION IN ADULTS AND CHILDREN1 (1970) (192)
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection (1986) (184)
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. (1986) (184)
Eaton agent pneumonia. (1961) (179)
Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. (1961) (177)
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. (1992) (176)
Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection (1976) (174)
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a (1989) (173)
Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics. (1973) (168)
ASSOCIATION OF A NEW TYPE OF CYTOPATHOGENIC MYXOVIRUS WITH INFANTILE CROUP (1956) (166)
Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus) (1993) (166)
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection (1986) (166)
Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children** (1977) (165)
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. (1983) (164)
Comparison of direct electron microscopy, immune electron microscopy, and rotavirus enzyme-linked immunosorbent assay for detection of gastroenteritis viruses in children (1981) (159)
Definition of human rotavirus serotypes by plaque reduction assay (1982) (158)
Solid‐phase microtiter radioimmunoassay for detection of the Norwalk strain of acute nonbacterial, epidemic gastroenteritis virus and its antibodies (1978) (157)
Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. (1986) (157)
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. (1987) (156)
A complement-fixation test for measuring Australia antigen and antibody. (1969) (156)
Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen (1988) (154)
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections (1988) (153)
SEROLOGICAL RELATIONSHIPS AMONG HUMAN MYCOPLASMAS AS SHOWN BY COMPLEMENT-FIXATION AND GEL DIFFUSION (1963) (153)
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines (1982) (153)
Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens (1981) (149)
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV. (1992) (148)
Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation (1986) (146)
A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. (1966) (144)
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies (1988) (142)
Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. (1981) (142)
Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. (1973) (140)
Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. (1972) (138)
Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. (1977) (136)
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. (1994) (134)
INFLUENZA A AND B VIRUS INFECTION IN INFANTS AND YOUNG CHILDREN DURING THE YEARS 1957–1976 (1979) (134)
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. (1986) (134)
Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses (1981) (133)
Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats (1987) (133)
Comparison of human and animal rotavirus strains by gel electrophoresis of viral RNA. (1978) (133)
Distinctive ribonucleic acid patterns of human rotavirus subgroups 1 and 2 (1981) (133)
Influence of immunological factors in respiratory syncytial virus disease. (1970) (133)
Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. (1987) (131)
Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. (1980) (129)
Rotavirus VP7 neutralization epitopes of serotype 3 strains. (1989) (128)
INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS. (1964) (127)
Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. (1979) (127)
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children (1982) (125)
A seroepidemiologic study of adenovirus-associated virus infection in infants and children. (1971) (124)
Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus (1983) (124)
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. (1994) (122)
Mechanisms of immunity to respiratory syncytial virus in cotton rats (1983) (122)
Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations. (1970) (121)
Respiratory syncytial virus infection in inbred mice (1979) (121)
Proteins of Norwalk virus (1981) (120)
Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. (2003) (117)
Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man. (1972) (117)
Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. (1967) (116)
MYCOPLASMA SPECIES OF MAN. (1965) (116)
Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract (1985) (115)
Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. (1995) (113)
Prediction of human rotavirus serotype by nucleotide sequence analysis of the VP7 protein gene (1988) (113)
Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. (1979) (112)
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis (1988) (111)
Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. (1975) (110)
Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. (1989) (110)
Mycoplasma pneumoniae: Proposed Nomenclature for Atypical Pneumonia Organism (Eaton Agent) (1963) (109)
Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. (1979) (109)
Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. (1973) (108)
Morphogenesis of Avian Infectious Bronchitis Virus and a Related Human Virus (Strain 229E) (1967) (108)
Human reovirus-like agent infection. Occurrence in adult contacts of pediatric patients with gastroenteritis. (1977) (108)
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. (1980) (107)
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus (1988) (107)
Biophysical Properties of Australia Antigen (1969) (107)
Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. (1988) (107)
Hemolysin of Mycoplasma pneumoniae: Tentative Identification as a Peroxide (1965) (107)
The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. (1967) (106)
Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. (1971) (106)
IMMUNIZATION WITH TYPES 4 AND 7 ADENOVIRUS BY SELECTIVE INFECTION OF THE INTESTINAL TRACT. (1963) (106)
Virulence of Avian Influenza A Viruses for Squirrel Monkeys (1982) (105)
Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4 (1986) (105)
Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. (1969) (104)
A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. (1994) (103)
Experimental respiratory syncytial virus infection of four species of primates (1977) (103)
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. (1986) (103)
Conservation of amino acid sequence of VP8 and cleavage region of 84-kDa outer capsid protein among rotaviruses recovered from asymptomatic neonatal infection. (1986) (100)
A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. (1993) (100)
Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses. (1985) (100)
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses (1988) (100)
Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). (1975) (99)
Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge. (2000) (99)
Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis (1989) (99)
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. (2003) (98)
Mycoplasma infections of man. (1965) (97)
Ear involvement (myringitis) and primary atypical pneumonia following inoculation of volunteers with Eaton agent. (1962) (96)
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. (1980) (96)
Low-temperature-grown RS virus in adult volunteers. (1968) (95)
Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers. (1966) (94)
Isolation from Man of “Avian Infectious Bronchitis Virus-like” Viruses (Coronaviruses*) similar to 229E Virus, with Some Epidemiological Observations (1969) (94)
Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. (1967) (94)
Secretory antibody directed against rotavirus in human milk--measurement by means of enzyme-linked immunosorbent assay. (1978) (92)
Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease. (1962) (92)
Nonviral oligonucleotides at the 5′ terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences (1980) (91)
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. (1999) (91)
Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. (1971) (90)
Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. (1985) (90)
Growth of Eaton PPLO in Broth and Preparation of Complement Fixing Antigen (1962) (90)
Experimental infection of chimpanzees with the Norwalk agent of epidemic viral gastroenteritis (1978) (90)
Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. (1994) (90)
Respiratory syncytial virus. III. Production of illness and clinical observations in adult volunteers. (1961) (88)
Respiratory syncytial virus. IV. Correlation of virus shedding, serologic response, and illness in adult volunteers. (1961) (87)
A microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools. (1977) (85)
Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay (1978) (85)
INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA. (1964) (84)
EXUDATIVE PHARYNGITIS FOLLOWING EXPERIMENTAL MYCOPLASMA HOMINIS: TYPE 1 INFECTION. (1965) (84)
Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. (1969) (84)
Respiratory syncytial virus. II. Serologic studies over a 34-month period of children with bronchiolitis, pneumonia, and minor respiratory diseases. (1961) (83)
Temperature-sensitive Mutants of Respiratory Syncytial Virus (1969) (83)
Rhinoviruses: a description. (1963) (83)
Differentiation of human and calf reoviruslike agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA. (1976) (82)
Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys. (1982) (82)
Prevalence of antibody to the Norwalk virus in various countries (1979) (81)
Respiratory disease in volunteers infected with Eaton agent: a preliminary report. (1961) (81)
Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. (1967) (80)
Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. (2000) (79)
Role of early genes in pathogenesis of adenovirus pneumonia. (1990) (79)
Genetic Relatedness Among Human Rotaviruses as Determined by RNA Hybridization (1982) (78)
Molecular approaches to the control of infectious diseases (1995) (77)
Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. (2006) (76)
In vitro transcription of two human rotaviruses (1982) (74)
Antigenic Differences Between Two Strains of Respiratory Syncytial Virus (1963) (74)
Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus (1987) (73)
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. (2005) (73)
III. Myxoviruses: Parainfluenza (1962) (73)
Use of transcription probes for genotyping rotavirus reassortants. (1982) (72)
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. (1992) (71)
A collaborative report: rhinoviruses--extension of the numbering system. (1971) (71)
Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (SV40) by Respiratory Route (1961) (71)
In vitro cultivation in human fetal intestinal organ culture of a reovirus-like agent associated with nonbacterial gastroenteritis in infants and children. (1974) (71)
Ecology of Mycoplasma pneumoniae infections in marine recruits at Parris Island, South Carolina. (1969) (71)
Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors. (1965) (71)
Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. (1992) (70)
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. (1990) (70)
Comparative sequence analysis of the genomic segment 6 of four rotaviruses each with a different subgroup specificity. (1988) (69)
Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease. (1966) (69)
Eaton agent pneumonia-clinical features. (1961) (68)
Enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species. (1978) (67)
Mutants of influenza virus. (1969) (66)
An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. (1961) (66)
SIGNIFICANCE OF ANTIBODY TO MYCOPLASMA AS MEASURED BY METABOLIC‐INHIBITION TECHNIQUES (1967) (66)
Respiratory Syncytial Virus (1976) (65)
Experimental infection with respiratory syncytial virus in several species of animals. (1962) (65)
Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitation. (1972) (65)
Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. (1969) (64)
A NEWLY IDENTIFIED ORAL MYCOPLASMA (M. ORALE) AND ITS RELATIONSHIP TO OTHER HUMAN MYCOPLASMAS. (1964) (64)
Para-influenza viruses 1, 2, and 3: suggested names for recently described myxoviruses. (1959) (63)
Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay (1978) (63)
Evaluation of an interferon inducer in viral respiratory disease. (1972) (62)
Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood. (1960) (62)
An inactivated mycoplasma pneumoniae vaccine. (1965) (62)
Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection (1978) (61)
Genetic relatedness among human rotaviruses (1985) (61)
EPIDEMIOLOGY OF M. PNEUMONIAE INFECTION IN MILITARY RECRUITS (1967) (61)
Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection. (1966) (60)
Antibody to Mycoplasma pneumoniae in Nasal Secretions and Sputa of Experimentally Infected Human Volunteers (1973) (60)
Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. (1981) (59)
Studies of a new human hemadsorption virus. I. Isolation, properties and characterization. (1960) (59)
Common exposure outbreak of gastroenteritis due to type 2 rotavirus with high secondary attack rate within families. (1979) (59)
Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. (1977) (58)
Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. (1973) (58)
Seroepidemiological studies of transfusion-associated hepatitis. (1971) (57)
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin (1977) (57)
Antigenic relationships among the newer myxoviruses (parainfluenza). (1959) (57)
Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines (1999) (56)
Enhancement of Respiratory Syncytial Virus Pulmonary Pathology in Cotton Rats by Prior Intramuscular Inoculation of Formalin-Inactivated Virus (1986) (56)
ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS. (1964) (55)
Density in cesium chloride of the 27 nm "8FIIa" particle associated with acute infectious nonbacterial gastroenteritis: determination by ultra-centrifugation and immune electron microscopy. (1973) (55)
Diarrhea associated with rotavirus in rural Guatemala: a longitudinal study of 24 infants and young children. (1979) (55)
Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. (1996) (54)
Illness and Microbial Experiences of Nursery Children at Junior Village. (1961) (54)
Significance of Antibody to Mycoplasma hominis Type 1 as Measured by Indirect Hemagglutination (1965) (53)
Comparative analysis of the VP3 gene of divergent strains of the rotaviruses simian SA11 and bovine Nebraska calf diarrhea virus (1988) (53)
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers (1981) (53)
Newly recognized respiratory tract viruses. (1958) (52)
Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo (1987) (52)
Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. (1971) (52)
Cold-Adapted Variants of Influenza A Virus: Evaluation in Adult Seronegative Volunteers of A/Scotland/840/74 and A/Victoria/3/75 Cold-Adapted Recombinants Derived from the Cold-Adapted A/Ann Arbor/6/60 Strain (1979) (51)
Immunogenicity of Mycoplasma pneumoniae glycolipids: a novel approach to the production of antisera to membrane lipids. (1970) (51)
Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. (1986) (51)
Association of hemadsorption viruses with respiratory illness in childhood. (1959) (50)
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. (1970) (50)
Hemolyin production as an aid in the identification and quantitation of Eaton agent (Mycoplasma pneumoniae). (1963) (49)
Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. (1972) (49)
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. (1998) (49)
Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines (1980) (49)
Clinical features of infection with hemadsorption viruses. (1959) (48)
Temperature-sensitive mutants of influenza. VIII. Genetic and biological characterization of TS mutants of influenza virus A (H3N2) and their assignment to complementation groups. (1975) (48)
Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. (1996) (48)
Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats (1982) (47)
Analysis by RNA-RNA hybridization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo (1987) (47)
Studies in volunteers with human rotaviruses. (1983) (47)
VP7 serotype-specific glycoprotein of OSU porcine rotavirus: coding assignment and gene sequence. (1986) (47)
RECOVERY OF PARAINFLUENZA VIRUSES FROM ADULTS WITH UPPER RESPIRATORY ILLNESS (1961) (46)
Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. (1980) (45)
Dose response of influenza A/Washington/897/80 (H3N2) avian-human reassortant virus in adult volunteers. (1985) (45)
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. (2006) (45)
Role of Glycolipids and Phosphatidylglycerol in the Serological Activity of Mycoplasma pneumoniae (1970) (45)
Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease. (1980) (45)
Experimental respiratory syncytial virus pneumonia in cebus monkeys (1978) (45)
Inoculation of human volunteers with parainfluenza virus type 3. (1961) (44)
Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines. (1989) (44)
Genetic Differentiation by Nucleic Acid Homology I. Relationships Among Mycoplasma Species of Man (1966) (43)
The remaining stocks of smallpox virus should be destroyed. (1993) (42)
Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine. (1972) (42)
Control of acute mycoplasmal and viral respiratory tract disease. (1970) (42)
Role of Eaton Agent in Disease of Lower Respiratory Tract (1960) (42)
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. (1988) (42)
Measurement of Mycoplasma pneumoniae mycoplasmacidal antibody in human serum. (1972) (42)
Establishment of human fetal intestinal organ cultures for growth of viruses. (1970) (42)
Respiratory syncytial virus in infants and children. (1974) (42)
Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats (1990) (41)
Association of type 2 hemadsorption (parainfluenza 1) virus and Asian influenza A virus with infections croup. (1959) (41)
Respiratory Syncytial Virus Neutralizing Activity in Nasal Secretions Following Natural Infection∗ (1969) (41)
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. (1970) (41)
Vaccines 85 : molecular and chemical basis of resistance to parasitic, bacterial, and viral diseases (1985) (41)
Immunologic studies of Japanese encephalitis virus in Japan. I. Antibody responses following overt infection of man. (1959) (41)
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. (1976) (41)
Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae. (1974) (40)
ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA IN A MILITARY POPULATION. (1965) (40)
Isolation and Characterization of Fractions of Mycoplasma pneumoniae II. Antigenicity and Immunogenicity (1966) (40)
Immunofluorescence with respiratory syncytial virus. (1962) (40)
Cloning DNA sequences from influenza viral RNA segments. (1980) (39)
Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant (1992) (39)
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection (1986) (39)
A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. (1990) (38)
Avian-human reassortant influenza A viruses derived by mating avian and human influenza A viruses. (1984) (38)
CHARACTERIZATION OF A NEWLY IDENTIFIED MYCOPLASMA FROM THE HUMAN OROPHARYNX. (1965) (38)
Temperature sensitive mutants of influenza virus. IX. Genetic and biological characterization of TS-1[E] lesions when transferred to a 1972 (H3N2) influenza A virus. (1975) (38)
Serologic response to Myocplasma pneumoniae infection. II. Significance of antibody measured by different techniques. (1966) (37)
Hemolysin of Mycoplasma pneumoniae (1965) (37)
Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants. (1989) (36)
Modern approaches to vaccines : molecular and chemical basis of virus virulence and immunogenicity (1984) (36)
Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys (1980) (36)
Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity. (1982) (36)
PATTERNS OF ILLNESS IN RHINOVIRUS INFECTIONS OF MILITARY PERSONNEL. (1963) (36)
Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus (1990) (36)
Recommendations on Nomenclature of the Order Mycoplasmatales: (1967) (36)
EFFECT OF NEUTRALIZING ANTIBODY ON EXPERIMENTAL RHINOVIRUS INFECTION. (1963) (35)
GENETIC DIFFERENTIATION BY NUCLEIC ACID HOMOLOGY. III. RELATIONSHIPS AMONG MYCOPLASMA, L‐FORMS, AND BACTERIA (1967) (35)
Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus (1975) (35)
ESCAPE OF A HIGHLY DEFECTIVE INFLUENZA A VIRUS MUTANT FROM ITS TEMPERATURE SENSITIVE PHENOTYPE BY EXTRAGENIC SUPPRESSION AND OTHER TYPES OF MUTATION (1980) (35)
Antigenic analysis of a putative new strain of respiratory syncytial virus. (1985) (35)
Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection. (1967) (34)
Infection of human volunteers with type 2 hemadsorption virus. (1958) (34)
Temperature-sensitive Mutants of Influenza A Virus: Response of Children to the Influenza A/Hong Kong/68-ts-1[E] (H3N2) and Influenza A/Udorn/72-ts-1[E] (H3N2) Candidate Vaccine Viruses and Significance of Immunity to Neuraminidase Antigen (1976) (34)
Sensitivity of common respiratory viruses to an interferon inducer in human cells. (1969) (34)
Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children (1976) (34)
WHO respiratory disease survey in children: a serological study. (1967) (34)
Genetic Differentiation by Nucleic Acid Homology II. Genotypic Variations Within Two Mycoplasma Species (1966) (33)
Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children. (1988) (33)
RELATIONSHIP OF RHINOVIRUS INFECTION TO MILD UPPER RESPIRATORY DISEASE. 1. RESULTS OF A SURVEY IN YOUNG ADULTS AND CHILDREN. (1963) (33)
Etiology of upper-respiratory-tract illnesses among civilian adults. (1966) (33)
Lysis and death of Mycoplasma pneumoniae by antibody and complement. (1971) (32)
Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. (1993) (32)
Neonatal Administration of Rhesus Rotavirus Tetravalent Vaccine (2006) (32)
VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies. (1989) (32)
Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats (1979) (32)
Studies of mouse polyoma virus infection. IV. Evidence for mucoprotein erythrocyte receptors in polyoma virus hemagglutination. (1959) (31)
Measurement of rotavirus antibody by an enzyme-linked immunosorbent assay blocking assay (1978) (31)
Role of mycoplasmas in human respiratory disease. (1967) (31)
Detection and Identification by Immune Electron Microscopy of Fastidious Agents Associated with Respiratory Illness, Acute Nonbacterial Gastroenteritis, and Hepatitis A (1975) (31)
Peroxide Formation by Mycoplasmas which Infect Man (1968) (31)
Inhibition of Respiratory syncytial, parainfluenza 3 and measles viruses by 2-deoxy-D-glucose. (1975) (31)
ROLE OF MYCOPLASMA (PPLO) IN HUMAN RESPIRATORY DISEASE. (1963) (31)
Temperature-Sensitive Mutants of Influenza A Virus: Evaluation of A/Victoria/3/75-ts-1[E] Recombinant Viruses in Volunteers (1978) (31)
More sensitive methods for detection of antibody to Mycoplasma pneumoniae. (1973) (30)
Serologic response of incividuals infected with para influenza viruses. (1960) (30)
Growth of Laboratory and Naturally Occurring Strains of Eaton Agent in Monkey Kidney Tissue Culture (1960) (30)
Genetic approaches to attenuation of influenza A viruses for man. (1980) (29)
Construction and characterization of cDNA clones for four respiratory syncytial viral genes. (1983) (29)
Live viral vaccines for respiratory and enteric tract diseases. (1988) (29)
Cold-adapted variants of influenza virus A. I. Comparison of the genetic properties of ts mutants and five cold-adapted variants of influenza virus A. (1977) (28)
A Radioimmunoprecipitation Test for Detection of Mycoplasma pneumoniae Antibody (1973) (28)
Current research on respiratory viral infections: Third International Symposium (2001) (28)
Respiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants (1979) (28)
Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. (1986) (28)
Evaluation of influenza virus mutants for possible use in a live virus vaccine. (1969) (28)
Infectivity and antigenicity of live avian-human influenza A reassortant virus: comparison of intranasal and aerosol routes in squirrel monkeys. (1986) (28)
Use of a free viral immunofluorescence assay to detect human reovirus-like agent in human stools (1977) (28)
Density of Infectious Virus and Complement-Fixing Antigens of Two Rhinovirus Strains (1966) (28)
Temperature-sensitive mutants of Mycoplasma pneumoniae. I. In vitro biologic properties. (1969) (28)
Temperature-sensitive mutants of influenza virus. XVI. Transfer of the two ts lesions present in the Udorn/72-ts-1A2 donor virus to the Victoria/3/75 wild-type virus. (1978) (27)
Genetic stability of rotaviruses recovered from asymptomatic neonatal infections (1988) (27)
Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children. (1989) (27)
Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. (1998) (26)
Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. II. Genetic analysis and demonstration of intrasegmental complementation. (1982) (26)
Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. III. Genetic analysis of temperature-dependent host range mutants. (1983) (26)
Experimental Mycoplasma pneumoniae infection of young guinea pigs. (1973) (26)
Temperature-sensitive mutants of influenza virus. Identification of the loci of the two ts lesions in the Udorn-ts-1A2 donor virus and the correlation of the presence of these two ts lesions with a predictable level of attenuation. (1980) (26)
Isolation and Characterization of Fractions of Mycoplasma pneumoniae I. Chemical and Chromatographic Separation (1966) (24)
The hemagglutinin of St. Louis encephalitis virus. I. Recovery of stable hemagglutinin from the brains of infected mice. (1953) (24)
Relationship of Human and Bovine Strains of Myxovirus Para-Influenza 3 (1961) (24)
Temperature-sensitive mutants of influenza virus. V. Evaluation in man of an additional ts recombinant virus with a 39 C shutoff temperature. (1974) (24)
Identification of acid-inducing agent and related mycoplasma as mycoplasma hyorhinis. (1966) (24)
Recovery and identification of adenovirus in infections of infants and children. (1965) (23)
Temperature-sensitive mutants of Mycoplasma pneumoniae. II. Response of hamsters. (1971) (23)
Serious respiratory tract illness as a result of Asian influenza and influenza B infections in children. (1962) (23)
IV. Respiratory Syncytial Virus (1962) (23)
In vivo antigenic studies of parainfluenza viruses. (1963) (23)
Temperature-sensitive mutants of influenza A virus. XI. Transfer of ts lesions in the Hong Kong/68-ts-1 [a] virus to the influenza A/Udorn/72 wild type. (1976) (22)
Temperature-sensitive mutants of influenza virus XV. The genetic and biological characterization of a recombinant influenza virus containing two is lesions produced by mating two complementing, single lesion is mutants (1978) (22)
Enhancement of antigen incorporation and infectivity of cell cultures by human rotavirus (1979) (22)
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses (1982) (21)
Electron microscopy of solubilized Acholeplasma laidlawii membrane proteins reaggregated with Mycoplasma pneumoniae glycolipids. (1971) (21)
Evaluation of five temperature‐sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection (1978) (21)
Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus (1977) (21)
Picornaviruses: classification of nine new types. (1963) (21)
From the National Institutes of Health (1973) (20)
RECOVERY OF A NEW TYPE OF MYXOVIRUS FROM INFANTS WITH CROUP (1957) (20)
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults. (1977) (20)
Induction of diarrhea in colostrum-deprived newborn rhesus monkeys with the human reovirus-like agent of infantile gastroenteritis (2005) (20)
Immunization of infants and young children against rotaviral gastroenteritis--prospects and problems. (1978) (20)
Para-influenza 2 (CA) virus: etiologic association with croup. (1961) (20)
Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys (1988) (20)
SEROLOGICAL AND IMMUNOGENIC ACTIVITIES OF DIFFERENT FRACTIONS OF MYCOPLASMA PNEUMONIAE (1967) (20)
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers (1979) (19)
Viral diarrhea. Etiology and control (1978) (19)
Joseph E. Smadel memorial lecture. Strategy for development of respiratory and gastrointestinal tract viral vaccines in the 1980s. (1981) (19)
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine (1977) (19)
Potential of attenuated respiratory syncytial virus vaccine for infants and children. (1975) (19)
128. An outbreak of parainfluenza 2 (croup associated) virus infection (1963) (18)
Parenteral Immunization with Live Respiratory Syncytial Virus Is Blocked in Seropositive Cotton Rats (1982) (18)
Localization of the Ts defect in two Ts mutants of influenza A virus: evidence for the occurrence of intracistronic complementation between Ts mutants of influenza A virus coding for the neuraminidase and nucleoprotein polypeptides. (1980) (18)
PATTERNS OF ADENOVIRUS INFECTIONS IN MARINE CORPS PERSONNEL. I. A 42-MONTH SURVEY IN RECRUIT AND NONRECRUIT POPULATIONS. (1964) (18)
An outbreak of parainfluenza 2 (croup-associated) virus infection. Association with acute undifferentiated febrile illness in children. (1963) (18)
The hemagglutinin of St. Louis encephalitis virus. II. Physico-chemical properties and nature of its reaction with erythrocytes. (1953) (18)
Production and Properties of Antisera to Membrane Glycolipids of Mycoplasma pneumoniae (1971) (18)
Comparative biology and ecology of human virus and Mycoplasma respiratory pathogens. (1965) (18)
Demonstration of a non-temperature-sensitive growth-restricting mutation in a ts mutant of influenza A virus: implications for live virus vaccine development. (1977) (18)
Proposal of Mycoplasma buccale nom. nov. and Mycoplasma faucium nom. nov. for Mycoplasma orale “Types” 2 and 3, Respectively (1974) (17)
A mutant of Parainfluenza type 1 virus with decreased capacity for growth at 38 C and 39 C. (1970) (17)
Characterization of a Newly Identified Mycoplasma (Mycoplasma orale Type 3) from the Human Oropharynx (1969) (17)
Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus. (1970) (17)
Effect of 2-deoxy-D-glucose and glucosamine on the growth and functions of respiratory syncytial and parainfluenza 3 viruses. (1975) (16)
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters (1977) (16)
New viruses observed in children with respiratory diseases. (1958) (16)
Production and Level of Genetic Stability of an Influenza A Virus Temperature-Sensitive Mutant Containing Two Genes with ts Mutations (1982) (16)
Electrophoretic Analysis of Cell Proteins of T-Strain Mycoplasmas Isolated from Man (1970) (16)
ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus. (1980) (15)
The use of purified immunoglobulin in the therapy of respiratory syncytial virus infection. (1986) (15)
Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens. (1975) (15)
Impact of adenoviruses in human disease. (1974) (15)
RELATIONSHIP OF RHINOVIRUS INFECTION TO MILD UPPER RESPIRATORY DISEASE. II. EPIDEMIOLOGIC OBSERVATIONS IN MALE MILITARY TRAINEES. (1965) (15)
Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children. (1991) (15)
Clinical Syndromes Among Children1 (1963) (15)
PATTERNS OF ADENOVIRUS INFECTIONS IN MARINE CORPS PERSONNEL. II. LONGITUDINAL STUDY OF SUCCESSIVE ADVANCED RECRUIT TRAINING COMPANIES. (1964) (15)
Characterization of the temperature sensitive phenotype of the A/Ann Arbor/6/60 cold-adapted virus and its recombinants (1981) (14)
Eaton agent pneumonia. (1961) (14)
Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures (1976) (14)
A DESCRIPTION OF SIX NEW RHINOVIRUSES OF HUMAN ORIGIN. (1965) (14)
Primary Atypical Pneumonia Due to Mycoplasma pneumoniae (Eaton Agent) (1963) (14)
Vaccines 87 : modern approaches to new vaccines : prevention of AIDS and other viral, bacterial, and parasitic diseases (1987) (13)
The hemagglutinin of St. Louis encephalitis virus. III. Properties of normal inhibitors and specific antibody; use of hemagglutination-inhibition for diagnosis of infection. (1953) (13)
Recovery and identification of human myxoviruses. (1965) (13)
Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses. (1962) (13)
Immunologic studies of Japanese encephalitis virus in Japan. II. Antibody responses following inapparent human infection. (1959) (13)
Cultivation of Mycoplasmas on glass. (1971) (13)
Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro (1994) (13)
Family outbreak of primary atypical pneumonia associated with the Eaton agent. (1960) (13)
Biophysical Studies of Respiratory Syncytial Virus I. Density of Respiratory Syncytial Virus and Associated Complement-Fixing Antigens in a Cesium Chloride Density Gradient (1966) (13)
Experimental production of respiratory tract infection with Mycoplasma pneumoniae in rhesus monkeys. (1976) (12)
CLINICAL SIGNIFICANCE OF RESPIRATORY SYNCYTIAL VIRUS. (1964) (12)
The effect of an interferon inducer on influenza virus. (1969) (12)
Cytopathogenic Effect of Newcastle Virus in Monkey Kidney Cultures and Interference with Poliomyelitis Viruses.∗ (1955) (12)
Experimental production of respiratory tract disease in cebus monkeys after intratracheal or intranasal infection with influenza A/Victoria/3/75 or influenza A/New Jersey/76 virus (1978) (12)
A PILOT STUDY OF ACUTE RESPIRATORY ILLNESSES ON A COLLEGE CAMPUS. (1964) (12)
Genetic approaches to control of influenza. (1979) (12)
The hemagglutinin of West Nile virus: recovery, properties, and antigenic relationships. (1954) (12)
A study of the hemadsorption viruses (para-influenzae) and other viruses in children with and without respiratory disease. (1960) (12)
Relationship of Mycoplasma pneumoniae to Other Human Mycoplasma Species Studied by Gel Diffusion (1965) (11)
Temperature-Sensitive Mutants of Influenza Virus. III. Further (1973) (11)
VI. The Newer Enteroviruses (1962) (11)
Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. (1967) (11)
Development and use of influenza vaccines. (1981) (11)
GENETIC APPROACHES TO THE PREVENTION OF INFLUENZA A VIRUS INFECTION (1981) (11)
The hemagglutinin of western equine encephalitis virus: recovery, properties and use for diagnosis. (1954) (11)
Recent advances in the aetiology of viral gastroenteritis. (1976) (11)
Cold adapted variants of influenza A (1977) (11)
Mycoplasma lipophilum sp. nov. (1974) (11)
What biotechnology has to offer vaccine development. (1989) (11)
Respiratory syncytial virus antibodies in nonhuman primates and domestic animals. (1981) (11)
Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology. (1973) (11)
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. (1995) (10)
CLINICAL SYNDROMES AMONG CHILDREN. (1963) (10)
Vaccines 86: New Approaches to Immunization : Developing Vaccines Against Parasitic, Bacterial, and Viral Diseases (1986) (10)
Specificity of the local secretory antibody to influenza A virus infection. (1974) (10)
Development of vaccines against rotavirus disease. (1983) (10)
Temperature-sensitive mutants of influenza virus. XV. The genetic and biological characterization of a recombinant influenza virus containing two ts lesions produced by mating two complementing, single lesion ts mutants. (1978) (10)
Genetic studies of respiratory syneytial virus temperature-sensitive mutants (2005) (10)
Temperature-Sensitive Mutants of Influenza A Virus: Production and Characterization of A/Victoria/3/75-ts-1[E] Recombinants (1978) (9)
THE ROLE OF ENTEROVIRUSES IN RESPIRATORY DISEASE. (1963) (9)
Genetic relatedness among human rotavirus genes coding for VP7, a major neutralization protein, and its application to serotype identification (1987) (9)
Acute respiratory disease associated with Coxsackie A-21 virus infection. II. Incidence in military personnel: observations in a nonrecruit population. (1962) (9)
RHINOVIRUS NEUTRALIZING ANTIBODY RESPONSES AND THEIR MEASUREMENT. (1963) (9)
Electron microscopic studies of respiratory syneytial temperature-sensitive mutants (2005) (9)
Functional expression of influenza A viral nucleoprotein in cells transformed with cloned DNA. (1986) (9)
Ultrastructural Lesions in Mycoplasma pneumoniae Membranes Produced by Antibody and Complement (1973) (9)
Infection of Hamsters with Para Influenza 3 Virus (1960) (9)
Acute respiratory diseases of viral etiology. IV. Respiratory syncytial virus. (1962) (9)
Mycoplasma Species of Man (1965) (9)
V. Eaton Agent: A Review (1962) (9)
Hemagglutination by Coe virus. (1961) (9)
Immunogenicity of Cytolipin H Aggregated with Acholeplasma laidlawii Membrane Proteins (1971) (8)
Buoyant density in cesium chloride of the human reoviruslike agent of infantile gastroenteritis by ultracentrifugation, electron microscopy, and complement fixation. (1976) (8)
Genetic relatedness among animal rotaviruses (2005) (8)
Relationship of genotype of recombinants of influenza A/Hong Kong/68-ts-1[E]virus used as live virus vaccines to virulence in humans (1979) (8)
Biophysical Studies of Respiratory Syncytial Virus II. Identification of Two Soluble Complement-Fixing Antigens of Respiratory Syncytial Virus (1966) (8)
Respiratory Syncytial Virus Isolation by Combined Continuous Flow-Isopycnic Banding Centrifugation (1967) (8)
Solid-Phase Microtiter Radioimmunoassay Blocking Test for Detection of Antibodies to Escherichia coli Heat-Labile Enterotoxin (1979) (8)
Characterization of Two Newly Recognized Rhinovirus Serotypes of Human Origin. (1966) (8)
Serum Complement in Acute Bronchiolitis 1 (1970) (8)
Multiplication and Cytopathology of Coxsackie A-21 Virus in Rotated and Stationary Tissue Culture (1962) (8)
Growth of the Eaton Agent of Primary Atypical Pneumonia in Chick Entodermal Tissue Culture.∗ (1960) (8)
PHOSPHOLIPID HAPTEN OF MYCOPLASMA PNEUMONIAE (1967) (7)
Site-directed ELISA identifies a highly antigenic region of the simian immunodeficiency virus transmembrane glycoprotein. (1988) (7)
Immunization of monkeys with baculovirus recombinant-expressed dengue envelope and NS1 glycoproteins induces partial resistance to challenge with homotypic dengue virus. (1990) (7)
Relationship of rehinovirus infection to mild upper respiratory disease. 3. Further epidemiologic observations in military personnel. (1966) (7)
Evidence that the envelope protein of flaviviruses encodes determinants of attenuation and virulence. (1990) (7)
A Micro-Method for Assay of Neutralizing Antibodies Against Parainfluenza Virus Types 1 and 3 (1967) (7)
Mycoplasma pneumoniae Phosphatidyl Glycerol (1970) (7)
Evidence for intrasegmental complementation between two influenza A viruses having ts mutations on their P1 genes. (1982) (7)
Temperature-sensitive mutants of influenza A virus: transfer of the two temperature-sensitive lesions in the Udorn/72-ts-1A2 virus to the A2Hong Kong/123/77 (H1N1) wild-type virus. (1980) (6)
RNA segment 8 of the influenza virus genome contains two overlapping genes: Mapping the genes for polypeptides NS1 and NS2 (1980) (6)
Full protection against an immunodepressive viral disease by a recombinant antigen produced in yeast. (1990) (6)
Growth and genetic stability of 4 temperature sensitive(ts) mutants of respiratory syncytial (RS) virus in newborn ferrets (2005) (6)
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers. (1977) (6)
Control of Pediatric Viral Diseases: Past Successes and Future Prospects (1990) (6)
Mycoplasma infections of man. (1965) (6)
Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus. (1994) (6)
Lymphocyte proliferative responses to dengue virus E and NS1 proteins in BALB/c mice. (1990) (5)
The Hemadsorption Technique, with Special Reference to the Problem of Naturally Occurring Simian Para-influenza Virus1 (2015) (5)
Temperature-sensitive mutants of Streptococcus pneumoniae. I. Preparation and characterization in vitro of temperature-sensitive mutants of type I S. pneumoniae. (1977) (5)
Prospects for prevention of bronchiolitis caused by respiratory syncytial virus. (1977) (5)
Isolation of RNA Species from HeLa Cells Infected with Respiratory Syncytial Virus (1974) (5)
Temperature-sensitive mutants of influenza A virus: Evaluation of the Alaska/77-ts-1 A 2 temperature-sensitive recombinant virus in seronegative adult volunteers (2005) (5)
Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus (1977) (4)
Present status of live influenza A virus vaccine. (1979) (4)
Selection and analysis of protective epitopes on the E2 envelope of Semliki Forest virus. (1990) (4)
Live Victoria/75-ts-1[E] Influenza A Virus Vaccines in Adult Volunteers: Role of Hemagglutinin Immunity in Protection Against Illness and Infection Caused by Influenza A Virus (1979) (4)
MiceImmunized withRecombinant Vaccinia VirusExpressing Dengue4VirusStructural Proteins withor without Nonstructural Protein NS1AreProtected against Fatal DengueVirusEncephalitis (1989) (4)
Mycoplasma species in respiratorytract infections of childhood (1964) (4)
Acute respiratory diseases of viral etiology. V. Eaton agent: a review. (1962) (4)
PARAINFLUENZA VIRUS EPIDEMIOLOGY (1974) (4)
Characterization of antibody responses induced by different synthetic adjuvants to the Plasmodium falciparum major merozoite surface precursor protein, gp 195. (1990) (3)
Cold-Adapted Variants of Influenza Virus A (2003) (3)
Temperature-sensitive mutants of type I Streptococcus pneumoniae: preparation, characterization, and evidence for attenuation and immunogenicity. (1977) (3)
Temperature-sensitive mutants of influenza A virus. Transfer of the twots-1 A 2ts lesions present in the Udorn/72-ts-1 A 2 donor virus to the influenza A/Alaska/6/77 (H 3 N 2) wild type virus (2005) (3)
The role of respiratory syncytial virus, para influenza viruses, and Eaton agent in acute lower respiratory tract illness. (1962) (3)
Human T lymphocyte responses to dengue viruses: recognition of dengue virus proteins by T lymphocytes. (1990) (3)
Immunoenzymatic examination of autoptic tissues from the outbreak of fatal infantile disease in Naples, in 1978-1979. (1981) (3)
New opportunities for development of safe, effective live virus vaccines. (1982) (3)
810 HUMAN ROTAVIRUS (HRV) AND HEAT LABILE ENTEROTOXIN (LT) DETECTION IN A PEDIATRIC POPULATION (1978) (3)
Probable association of plaque size with neuraminidase subtype among H3N2 influenza A viruses (2005) (3)
USE OF AVIAN-HUMAN REASSORTANT INFLUENZA A VIRUSES AS LIVE VACCINE VIRUSES IN MAN (1984) (3)
Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971. (2004) (3)
1074 SAFETY AND IMMUNOGENICITY OF A LIVE ATTENUATED RHESUS MONKEY ROTAVIRUS VACCINE (1985) (2)
Letter: Probable in-vitro cultivation of human reovirus-like agent of infantile diarroea. (1976) (2)
Protective immunity against Newcastle disease virus induced by fowl poxvirus recombinants. (1990) (2)
Infectious disease: respiratory viruses. (1961) (2)
[Nucleoprotein and membrane protein genes responsible for restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in the respiratory tract of squirrel monkeys]. (1986) (2)
Ecology of a newly recognized common respiratory agent RS virus. Combined clinical staff conference at the National Institutes of Health. (1961) (2)
Mycoplasma pneumonia. (1966) (2)
Influence of immunologic factors in RS virus disease of the lower respiratory tract (1970) (2)
The Hemagglutinin of St. Louis Encephalitis Virus (1953) (2)
Acute respiratory diseases of viral etiology. VI. The newer enteroviruses. (1962) (2)
Erythrocyte rosetting and endothelial cytoadherence in Plasmodium falciparum malaria: implications for vaccine development. (1990) (2)
Nonbacterial gastroenteritis. (1976) (2)
Isolation and Characterization of Fractions of Mycoplasma pneumoniae (2003) (1)
Experimental Respiratory Syncytial Virus Infection of Adults (1971) (1)
[The focusing on and use of anti-influenza vaccines]. (1981) (1)
Molecular cloning of rotaviral genes implications for immunoprophylaxis (1984) (1)
Expression of antigenically active dengue-1 virus proteins using recombinant baculoviruses. (1990) (1)
Molecular basis of antigenicity and attenuation of a flavivirus: tick-borne encephalitis virus. (1990) (1)
Recombinant vaccine against coccidiosis: isolation and properties of a fusion protein. (1990) (1)
Reminiscences of Albert Sabin and his successful strategy for the development of the live oral poliovirus vaccine. (1996) (1)
Vaccination against pediatric illness caused by parainfluenza virus, respiratory syncytial virus and certain adenoviruses. Current status and perspective. (1970) (1)
Careers in Virology: a Good Beginnings is Usually Required for a Good Ending (1991) (1)
CURRENT APPROACHES TO VIRAL IMMUNOPROPHYLAXIS (1975) (1)
INTRAVENOUS IMMUNE SERUM GLOBULIN (IVIG) FOR PROPHYLAXIS AND TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV)) INFECTIONE IN THE COTTON RAT (1984) (1)
Antigenic relationships of human and animal rotaviruses as determined by antisera to baculovirus-recombinant expressed VP4 proteins. (1990) (1)
STRUCTURAL ANALYSIS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS GENOME (1984) (1)
Insertion of cellular sequences in the genome of a togavirus. (1990) (1)
RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE 1 - 2 (2005) (1)
The vaccine compositions containing the attenuated respiratory syncytial virus (1993) (0)
A method for detecting respiratory syncytial virus (2002) (0)
Avian-human influenza a reassortant viruses — Evaluation in humans and characterization of the genes specifying restricted replication in primates (1985) (0)
Recovery and identification of human myxoviruses (1965) (0)
Immunotherapy ofRespiratory Syncytial VirusInfection ofCotton Rats (1990) (0)
Abstracts of papers presented at the 1985 Meeting on Modern Approaches to Vaccines, September 11-September 15, 1985 (1985) (0)
Construction and characterization of cDNA clones for four respiratory syncytial viral genes ( cDNA (0)
Nucleoprotein andMembraneProtein GenesAreAssociated with Restriction ofReplication ofInfluenza A/Mallard/NY/78 Virusand ItsReassortants inSquirrel MonkeyRespiratory Tract (1985) (0)
Chimeric of West Nile virus and dengue-4 virus for use in a live virus vaccine for the prevention of disease caused by the West Nile Virus (2003) (0)
Presentation of Howland Award to Dr. Albert Sabin, May 1, 1974 (1974) (0)
CELL MEDIATED IMMUNITY CONFERRED BY NATURAL RSV INFECTION AND KILLED VACCINE (1974) (0)
STUDIES OF MOUSE POLYOMA VIRUS INFECTION (1959) (0)
Chimeric and / or growth-inhibited flaviviruses (1992) (0)
360 INFLUENZA A AND B VIRUS INFECTION IN INFANTS AND YOUNG CHILDREN DURING THE YEARS 1957–1976 (1978) (0)
Perspectives in Virology by Morris Pollard, University of Texas, Medical Branch. 312 pages, illustrated. New York, John Wiley & Sons, Inc., 1959. $7.00 (1959) (0)
INTRAVENOUS IMMUNE GLOBULIN (IVIG) FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS: STUDIES IN THE OWL MONKEY (1984) (0)
Isolation andCharacterization ofaChimpanzee Monoclonal Antibody totheG Glycoprotein ofHumanRespiratory Syncytial Virus (1994) (0)
Recovery andIdentification ofHumanMyxoviruses (1965) (0)
Blackman, Kenneth E. -- 1963-69 -- Correspondence, Individual -- letter, 1963-08-12 (1963) (0)
EVALUATION OF A NEW ANALEPTIC: ETHAMIVAN (EMIVAN). (1964) (0)
Analysis of the type 13 rhinovirus. (1970) (0)
Reports on ECHO-28 Virus-Reply (1964) (0)
Chimeric vaccine against the tick encephalitis virus (1998) (0)
Genetic Differentiation byNucleic AcidHomology I. Relationships AmongMycoplasma Species ofMan (1966) (0)
Chimpanzee Correspondence -- 1954-56 -- Animals, NFIP -- letter, 1956-02-29 (1956) (0)
Temperature-Sensitive Mutants of Influenza Virus. Tissue Culture and in Experimental Animals I. Behavior in (1971) (0)
Hemagglutinins of the St. Louis and western equine encephalitis viruses: isolation, properties, and use for diagnosis and epidemiologic survey. (1952) (0)
Asymptomatic Infection ofAdultVolunteers withaTemperature Sensitive Mutant ofMycoplasma pneumoniae (1974) (0)
Independent segregation of two antigenic specificities ( VP 3 and VP 7 ) involved in neutralization of rotavirus infectivity ( intertypic rotavirus / rotaviral gene 4 / antigenic characterization / new classification system ) (0)
Useofa FreeViralImmunofluorescence AssaytoDetect HumanReovirus-Like AgentinHumanStools (1977) (0)
Consistent inhibition of the growth of BLV in sheep inoculated with the vaccinia-retrovirus env gene recombinant. (1990) (0)
Temperature-Sensitive Mutants ofInfluenza AVirus: Production andCharacterization ofA/Victoria/3/75- (1978) (0)
Cellular Biology and Myxovirus Infections (2015) (0)
TOWARD A QUANTITATIVE VIEW OF THE ENGRAM* (2003) (0)
Vaccin a rotavirus attenue humain (1995) (0)
Improved immunotherapeutic method for prevention or treatment of viral diseases of the respiratory tract (1991) (0)
Letter from Robert Chanock, National Institute of Allergy and Infectious Diseases to Barbara Hatch Rosenberg (1990) (0)
Neutralizing monoclonal antibodies to human respiratory syncytial virus. (1993) (0)
CYTOPATHOGENIC MYXOVIRUS WITH INFANTILE CROUP 3 roller tubes of monkey kidney (0)
Pneumonia in Cotton Rats (0)
A genetically engineered marker vaccine and a companion diagnostic test for the control of pseudorabies virus. (1990) (0)
PEPSCAN-based amino acid modifications of a Plasmodium falciparum pfs25 peptide sequence substantially increase reactivity with transmission-blocking monoclonal antibodies. (1990) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- letter, 1958-02-11 (1950) (0)
Chanock, Robert -- 1960-69 -- Correspondence, Individual -- letter, 1960-03-01 (1962) (0)
Some Properties of Strains 22 YE and OC 43 ( 36224 ) (2008) (0)
Rotavirus reassortant and its preparation (1993) (0)
Temperature-Sensitive Mutants of Influenza A Virus: Evaluation of the A/Victoria/75-ts-lA2 (2003) (0)
Vaccines 90: modern approaches to new vaccines including prevention of AIDS: vaccines 90. (1990) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- letter, 1949-11-05 (1949) (0)
Hemadsorption viruses in infections of the respiratory tract of children; preliminary report. (1959) (0)
Process for the production of human monoclonal antibodies (1995) (0)
A model for in vitro development of live, recombinant alphavirus vaccines. (1990) (0)
Abstracts of papers presented at the 1984 Meeting on Modern Approaches to Vaccines, September 12-September 16, 1984 (1984) (0)
Letter from Robert Chanock to Joshua Lederberg (1990) (0)
Morphogenesis ofAvianInfectious Bronchitis Virus anda Related HumanVirus(Strain 229E) (1967) (0)
Chimpanzee Correspondence -- 1954-56 -- Animals, NFIP -- letter, 1955-10-07 (1955) (0)
Safety and antigenicity of inactivated influenza virus vaccines in children: trials with monovalent and bivalent A/New Jersey/76 (HswN1) and A/Victoria/75 virus vaccines in Washington, D.C.. (1977) (0)
1987 -- Correspondence, Miscellaneous -- letter, 1987-08-06 (1987) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- letter, 1954-04-05 (1950) (0)
Genetic approaches to control of influenza. (1979) (0)
Evaluation of attenuated rotavirus (RV) vaccines for the prevention of severe diarrhea in infants and young children (1992) (0)
Improved immunotherapeutic method for preventing or treating viral diseases of the respiratory tract (1991) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- letter, 1953-07-27 (1951) (0)
Compositions de vaccins a base de virus respiratoire syncytial attenue (1993) (0)
Eaton agent pneumonia.(MR 005.09-1204.4). (1961) (0)
1958 -- Correspondence, Unsorted -- letter, 1958-02-25 (1958) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- letter, 1950-12-02 (1950) (0)
Cultivation of Mycoplasmas on Glass (1971) (0)
Abstracts of papers presented at the 1990 Meeting on Modern Approaches to New Vaccines : including prevention of AIDS, September 12-September 16, 1990 (1990) (0)
Recovery and identification of adenovirus in infections of infants and children (1965) (0)
Construction and characterization respiratory syncytial viral genes (cDNA library/hybrid selection and cell-free translation/respiratory (2016) (0)
Administration ofaHighly Attenuated, LiveRespiratory Syncytial Virus Vaccine toAdults andChildren (1982) (0)
Chanock, Robert -- 1950-59 -- Correspondence, Individual -- text, 1953 - 1959? (1953) (0)
RECENT PROGRESS IN THE DEVELOPMENT AND ASSESSMENT OF LIVE ATTENUATED VACCINES Chairman: PROFESSOR F. M. DAVENPORT (2008) (0)
Recovery of PPLO of atypicalpneumonia on artificial agar medium. (MR005.1204). (1963) (0)
Neutralization Epitopes on VP7ofHumanRotavirus: Nucleotide Sequence Analysis of Antigenic Mutants Selected withMonoclonal Antibodies (1988) (0)

This paper list is powered by the following services:

Other Resources About Robert M. Chanock

en.wikipedia.org

What Schools Are Affiliated With Robert M. Chanock?

Robert M. Chanock is affiliated with the following schools:

Robert M. Chanock's Academic­Influence.com Rankings

Why Is Robert M. Chanock Influential?

Robert M. Chanock's Published Works

Published Works

Other Resources About Robert M. Chanock

What Schools Are Affiliated With Robert M. Chanock?

Robert M. Chanock's AcademicInfluence.com Rankings